Thomas L. Long

Corporate Officer/Principal at PLX PHARMA WINDDOWN CORP.

Health Technology

Profile

Thomas L.
Long is currently the VP-Manufacturing & Technical Operations at PLx Pharma, Inc. He previously worked as the SVP & General Manager-Manufacturing Operations at Adams Respiratory Therapeutics, Inc.

Thomas L. Long active positions

Companies	Position	Start
PLX PHARMA WINDDOWN CORP.	Corporate Officer/Principal	2017-09-18

All active positions of Thomas L. Long

Former positions of Thomas L. Long

Companies	Position	End
Adams Respiratory Therapeutics, Inc. Adams Respiratory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adams Respiratory Therapeutics, Inc. manufactures over-the-counter remedies for respiratory ailments. The company's products include Mucinex, Mucinex DM, Maximum Strength Mucinex, Mucinex DM, Mucinex D, and the Delsym. It is a subsidiary of Reckitt Benckiser Corp. Adams Respiratory Therapeutics is headquartered in Chester, NJ	Corporate Officer/Principal	-

See the detail of Thomas L. Long's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Thomas L. Long's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Adams Respiratory Therapeutics, Inc. Adams Respiratory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adams Respiratory Therapeutics, Inc. manufactures over-the-counter remedies for respiratory ailments. The company's products include Mucinex, Mucinex DM, Maximum Strength Mucinex, Mucinex DM, Mucinex D, and the Delsym. It is a subsidiary of Reckitt Benckiser Corp. Adams Respiratory Therapeutics is headquartered in Chester, NJ	Health Technology
PLx Pharma, Inc. PLx Pharma, Inc. Pharmaceuticals: MajorHealth Technology PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development and commercialization of a technology platform for approved drugs. It offers the PLxGuard delivery system, which uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs with a targeted release to select portions of the gastrointestinal (GI) tract. The company was founded by Ronald R. Zimmerman on November 12, 2002 and is headquartered in Dover, DE.	Health Technology